AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/223
MAPPING OF GENOMIC T(2-5)(P23-Q35) BREAK POINTS IN PATIENTS WITH ANAPLASTIC LARGE-CELL LYMPHOMA BY SEQUENCING LONG-RANGE PCR PRODUCTS
Authors: LUTHRA R PUGH WC WAASDORP M MORRIS W CABANILLAS F CHAN PK SARRIS AH
Citation: R. Luthra et al., MAPPING OF GENOMIC T(2-5)(P23-Q35) BREAK POINTS IN PATIENTS WITH ANAPLASTIC LARGE-CELL LYMPHOMA BY SEQUENCING LONG-RANGE PCR PRODUCTS, Hematopathology and molecular hematology, 11(3-4), 1998, pp. 173-183
HIGH SERUM INTERLEUKIN-6 LEVELS CORRELATE WITH A SHORTER FAILURE-FREESURVIVAL IN INDOLENT LYMPHOMA
Authors: FAYAD L CABANILLAS F TALPAZ M MCLAUGHLIN P KURZROCK R
Citation: L. Fayad et al., HIGH SERUM INTERLEUKIN-6 LEVELS CORRELATE WITH A SHORTER FAILURE-FREESURVIVAL IN INDOLENT LYMPHOMA, Leukemia & lymphoma, 30(5-6), 1998, pp. 563-571
APOPTOTIC INDUCTION IN TRANSFORMED FOLLICULAR LYMPHOMA-CELLS BY BCL-2DOWN-REGULATION
Authors: TORMO M TARI AM MCDONNELL TJ CABANILLAS F GARCIACONDE J LOPEZBERESTEIN G
Citation: M. Tormo et al., APOPTOTIC INDUCTION IN TRANSFORMED FOLLICULAR LYMPHOMA-CELLS BY BCL-2DOWN-REGULATION, Leukemia & lymphoma, 30(3-4), 1998, pp. 367
GENOMIC DNA AMPLIFICATION AND THE DETECTION OF T(2-5)(P23-Q35) IN LYMPHOID NEOPLASMS
Authors: SARRIS AH LUTHRA R CABANILLAS F MORRIS SW PUGH WC
Citation: Ah. Sarris et al., GENOMIC DNA AMPLIFICATION AND THE DETECTION OF T(2-5)(P23-Q35) IN LYMPHOID NEOPLASMS, Leukemia & lymphoma, 29(5-6), 1998, pp. 507-514
TUMOR-NECROSIS-FACTOR-ALPHA AND INTERFERON-GAMMA, BUT NOT HTLV-I TAX,ARE LIKELY FACTORS IN THE EPIDERMOTROPISM OF CUTANEOUS T-CELL LYMPHOMA VIA INDUCTION OF INTERFERON-INDUCIBLE PROTEIN-10
Authors: DALIANI D ULMER RA JACKOW C PUGH W GANSBACHER B CABANILLAS F DUVIC M SARRIS AH
Citation: D. Daliani et al., TUMOR-NECROSIS-FACTOR-ALPHA AND INTERFERON-GAMMA, BUT NOT HTLV-I TAX,ARE LIKELY FACTORS IN THE EPIDERMOTROPISM OF CUTANEOUS T-CELL LYMPHOMA VIA INDUCTION OF INTERFERON-INDUCIBLE PROTEIN-10, Leukemia & lymphoma, 29(3-4), 1998, pp. 315
USE OF THE INTERNATIONAL PROGNOSTIC INDEX AND THE TUMOR SCORE TO DETECT POOR-RISK PATIENTS WITH PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA -A STUDY OF 37 PREVIOUSLY UNTREATED PATIENTS
Authors: ROMAGUERA JE DIAZPAVON JR CARIAS L HAGEMEISTER FB MCLAUGHLIN P RODRIGUEZ MA SARRIS AH YOUNES A PRETI A BACHIER C LLERENA E CABANILLAS F
Citation: Je. Romaguera et al., USE OF THE INTERNATIONAL PROGNOSTIC INDEX AND THE TUMOR SCORE TO DETECT POOR-RISK PATIENTS WITH PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA -A STUDY OF 37 PREVIOUSLY UNTREATED PATIENTS, Leukemia & lymphoma, 28(3-4), 1998, pp. 295-306
ALTERNATING TRIPLE THERAPY FOR THE TREATMENT OF INTERMEDIATE GRADE AND IMMUNOBLASTIC LYMPHOMA
Authors: CABANILLAS F PAVON JRD HAGEMEISTER FB MCLAUGHLIN P RODRIGUEZ MA ROMAGUERA JE DONG K MOON T
Citation: F. Cabanillas et al., ALTERNATING TRIPLE THERAPY FOR THE TREATMENT OF INTERMEDIATE GRADE AND IMMUNOBLASTIC LYMPHOMA, Annals of oncology, 9(5), 1998, pp. 511-518
MANTLE CELL LYMPHOMA - CYTOMORPHOLOGY, TETRAPLOIDY, AND P53 ANOMALIESPREDICT POOR CLINICAL OUTCOME
Authors: TULBAH A KATZ R CARAWAY N KESSLER G ORDONEZ N CABANILLAS F
Citation: A. Tulbah et al., MANTLE CELL LYMPHOMA - CYTOMORPHOLOGY, TETRAPLOIDY, AND P53 ANOMALIESPREDICT POOR CLINICAL OUTCOME, Modern pathology, 11(1), 1998, pp. 45-45
OVERVIEW OF PROGNOSTIC FACTORS IN NON-HODGKINS-LYMPHOMA
Authors: MOORE DF CABANILLAS F
Citation: Df. Moore et F. Cabanillas, OVERVIEW OF PROGNOSTIC FACTORS IN NON-HODGKINS-LYMPHOMA, Oncology, 12(10), 1998, pp. 17-24
RITUXIMAB CHIMERIC ANTI-CD20 MONOCLONAL-ANTIBODY THERAPY FOR RELAPSEDINDOLENT LYMPHOMA - HALF OF PATIENTS RESPOND TO A 4-DOSE TREATMENT PROGRAM
Authors: MCLAUGHLIN P GRILLOLOPEZ AJ LINK BK LEVY R CZUCZMAN MS WILLIAMS ME HEYMAN MR BENCEBRUCKLER I WHITE CA CABANILLAS F JAIN V HO AD LISTER J WEY K SHEN D DALLAIRE BK
Citation: P. Mclaughlin et al., RITUXIMAB CHIMERIC ANTI-CD20 MONOCLONAL-ANTIBODY THERAPY FOR RELAPSEDINDOLENT LYMPHOMA - HALF OF PATIENTS RESPOND TO A 4-DOSE TREATMENT PROGRAM, Journal of clinical oncology, 16(8), 1998, pp. 2825-2833
HIGH-DOSE CHEMOTHERAPY FOR RELAPSED AND REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA - MEDIASTINAL LOCALIZATION PREDICTS FOR A FAVORABLE OUTCOME
Authors: POPAT U PRZEPIORK D CHAMPLIN R PUGH W AMIN K MEHRA R RODRIGUEZ J GIRALT S ROMAGUERA J RODRIGUEZ A PRETI A ANDERSSON B KHOURI I CLAXTON D DELIMA M DONATO M ANDERLINI P GAJEWSKI J CABANILLAS F VANBESIEN K
Citation: U. Popat et al., HIGH-DOSE CHEMOTHERAPY FOR RELAPSED AND REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA - MEDIASTINAL LOCALIZATION PREDICTS FOR A FAVORABLE OUTCOME, Journal of clinical oncology, 16(1), 1998, pp. 63-69
SUBDIAPHRAGMATIC STAGE-I AND STAGE-II HODGKINS-DISEASE - LONG-TERM FOLLOW-UP AND PROGNOSTIC FACTORS
Authors: LIAO ZX HA CS FULLER LM HAGEMEISTER FB CABANILLAS F TUCKER SL HESS MA COX JD
Citation: Zx. Liao et al., SUBDIAPHRAGMATIC STAGE-I AND STAGE-II HODGKINS-DISEASE - LONG-TERM FOLLOW-UP AND PROGNOSTIC FACTORS, International journal of radiation oncology, biology, physics, 41(5), 1998, pp. 1047-1056
HODGKINS-DISEASE - CORRELATION OF CLINICAL CHARACTERISTICS WITH PROBABILITIES FOR NEGATIVE LYMPHANGIOGRAM VS. NEGATIVE LAPAROTOMY FINDINGS IN PATIENTS WITH STAGE-I SUPRADIAPHRAGMATIC PRESENTATIONS VS. THOSE INPATIENTS WITH STAGE-II
Authors: FULLER LM MIRZA NQ PALMER JL DAVIS BR HA CS RODRIGUEZ MA HAGEMEISTER FB CABANILLAS F MCLAUGHLIN P BUTLER JJ NORTH LB MARTIN RG
Citation: Lm. Fuller et al., HODGKINS-DISEASE - CORRELATION OF CLINICAL CHARACTERISTICS WITH PROBABILITIES FOR NEGATIVE LYMPHANGIOGRAM VS. NEGATIVE LAPAROTOMY FINDINGS IN PATIENTS WITH STAGE-I SUPRADIAPHRAGMATIC PRESENTATIONS VS. THOSE INPATIENTS WITH STAGE-II, International journal of radiation oncology, biology, physics, 40(2), 1998, pp. 377-386
LOCALIZED PRIMARY NON-HODGKIN-LYMPHOMA OF THE BREAST
Authors: HA CS DUBEY P GOYAL LK HESS M CABANILLAS F COX JD
Citation: Cs. Ha et al., LOCALIZED PRIMARY NON-HODGKIN-LYMPHOMA OF THE BREAST, American journal of clinical oncology, 21(4), 1998, pp. 376-380
SALVAGE OF CHEMOTHERAPY FAILURES WITH CENTRAL LYMPHATIC IRRADIATION FOR FOLLICULAR LYMPHOMA - A FEASIBILITY STUDY
Authors: HA CS CABANILLAS F COX JD
Citation: Cs. Ha et al., SALVAGE OF CHEMOTHERAPY FAILURES WITH CENTRAL LYMPHATIC IRRADIATION FOR FOLLICULAR LYMPHOMA - A FEASIBILITY STUDY, Radiology, 209P, 1998, pp. 1163-1163
STAGE-I HODGKIN DISEASE - RADIATION-THERAPY AND CHEMOTHERAPY AT THE UNIVERSITY-OF-TEXAS M.D.-ANDERSON-CANCER-CENTER, 1967-1997
Authors: VLACHAKI MT HA CS HAGEMEISTER FB FULLER LM RODRIGUEZ MA HESS MA TUCKER SL CABANILLAS F COX JD
Citation: Mt. Vlachaki et al., STAGE-I HODGKIN DISEASE - RADIATION-THERAPY AND CHEMOTHERAPY AT THE UNIVERSITY-OF-TEXAS M.D.-ANDERSON-CANCER-CENTER, 1967-1997, Radiology, 208(3), 1998, pp. 739-747
COINCIDENT RENAL-CELL CARCINOMA AND NONHODGKINS LYMPHOMA - THE M.-D.-ANDERSON EXPERIENCE AND REVIEW OF THE LITERATURE
Authors: ANDERSON CM PUSZTAI L PALMER JL CABANILLAS F ELLERHORST JA
Citation: Cm. Anderson et al., COINCIDENT RENAL-CELL CARCINOMA AND NONHODGKINS LYMPHOMA - THE M.-D.-ANDERSON EXPERIENCE AND REVIEW OF THE LITERATURE, The Journal of urology, 159(3), 1998, pp. 714-717
UNBALANCED EXPRESSION OF FAS AND CD40 IN MANTLE CELL LYMPHOMA
Authors: CLODI K SNELL V ZHAO SR CABANILLAS F ANDREEFF M YOUNES A
Citation: K. Clodi et al., UNBALANCED EXPRESSION OF FAS AND CD40 IN MANTLE CELL LYMPHOMA, British Journal of Haematology, 103(1), 1998, pp. 217-219
COEXPRESSION OF CD40 AND CD40 LIGAND IN B-CELL LYMPHOMA-CELLS
Authors: CLODI K ASGARY Z ZHAO SR KLICHE KO CABANILLAS F ANDREEFF M YOUNS A
Citation: K. Clodi et al., COEXPRESSION OF CD40 AND CD40 LIGAND IN B-CELL LYMPHOMA-CELLS, British Journal of Haematology, 103(1), 1998, pp. 270-275
T(2-5) AND FAILURE-FREE SURVIVAL (FFS) OF DOXORUBICIN-TREATED ANAPLASTIC LARGE-CELL LYMPHOMA (ALCL)
Authors: HERLING M PUGH W MORRIS SW FALINI B CABANILLAS F SARRIS AH
Citation: M. Herling et al., T(2-5) AND FAILURE-FREE SURVIVAL (FFS) OF DOXORUBICIN-TREATED ANAPLASTIC LARGE-CELL LYMPHOMA (ALCL), British Journal of Haematology, 102(1), 1998, pp. 123-123
A 5' EXONUCLEASE-BASED REAL-TIME PCR (ERTPCR) ASSAY FOR DETECTION OF T(14-18) (Q32-Q21) IN FOLLICULAR LYMPHOMA
Authors: LUTHRA R MCBRIDE JA CABANILLAS F SARRIS AH
Citation: R. Luthra et al., A 5' EXONUCLEASE-BASED REAL-TIME PCR (ERTPCR) ASSAY FOR DETECTION OF T(14-18) (Q32-Q21) IN FOLLICULAR LYMPHOMA, British Journal of Haematology, 102(1), 1998, pp. 144-145
PRELIMINARY-REPORT OF A NEW ACTIVE REGIMEN FOR AGGRESSIVE MANTLE CELLLYMPHOMA
Authors: KHOURI IF ROMAGUERA J PALMER JL PUGH WC KORBLING M SAMUELS B GIRALT S RODRIGUEZ A PRZEPIORKA D MCLAUGHLIN P ANDERSSON B CLAXTON D MIRZA N MEHRA R HAGEMEISTER F CABANILLAS F CHAMPLIN R
Citation: If. Khouri et al., PRELIMINARY-REPORT OF A NEW ACTIVE REGIMEN FOR AGGRESSIVE MANTLE CELLLYMPHOMA, British Journal of Haematology, 102(1), 1998, pp. 240-241
THE CLINICAL-SIGNIFICANCE OF MOLECULAR RESPONSE IN INDOLENT FOLLICULAR LYMPHOMAS
Authors: LOPEZGUILLERMO A CABANILLAS F MCLAUGHLIN P SMITH T HAGEMEISTER F RODRIGUEZ MA ROMAGUERA JE YOUNES A SARRIS AH PRETI HA PUGH W LEE MS
Citation: A. Lopezguillermo et al., THE CLINICAL-SIGNIFICANCE OF MOLECULAR RESPONSE IN INDOLENT FOLLICULAR LYMPHOMAS, Blood, 91(8), 1998, pp. 2955-2960
RISK-FACTORS, TREATMENT, AND OUTCOME OF CENTRAL-NERVOUS-SYSTEM RECURRENCE IN ADULTS WITH INTERMEDIATE-GRADE AND IMMUNOBLASTIC LYMPHOMA
Authors: VANBESIEN K HA CS MURPHY S MCLAUGHLIN P RODRIGUEZ A AMIN K FORMAN A ROMAGUERA J HAGEMEISTER F YOUNES A BACHIER C SARRIS A SOBOCINSKI KS COX JD CABANILLAS F
Citation: K. Vanbesien et al., RISK-FACTORS, TREATMENT, AND OUTCOME OF CENTRAL-NERVOUS-SYSTEM RECURRENCE IN ADULTS WITH INTERMEDIATE-GRADE AND IMMUNOBLASTIC LYMPHOMA, Blood, 91(4), 1998, pp. 1178-1184
THE CLINICAL BEHAVIOR OF LOCALIZED AND MULTICENTRIC CASTLEMAN DISEASE
Authors: HERRADA J CABANILLAS F RICE L MANNING J PUGH W
Citation: J. Herrada et al., THE CLINICAL BEHAVIOR OF LOCALIZED AND MULTICENTRIC CASTLEMAN DISEASE, Annals of internal medicine, 128(8), 1998, pp. 657-662
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>